Is Legislation to Safeguard Americans Against Superbugs Pointless?

While supporters cheer the PASTEUR Act as an essential strategy to stem the rise of antibiotic-resistant pathogens, critics call it a multibillion-dollar giveaway to Big Pharma.

Related Keywords

United Kingdom ,Colorado ,United States ,Indiana ,Georgia ,Pennsylvania ,Americans ,America ,Mike Doyle ,Brad Spellberg ,Drew Ferguson ,Todd Young ,Reshma Ramachandran ,Thomas Frieden ,Michael Bennet ,Amanda Jezek ,Amesh Adalja ,John Powers ,Cornelius Clancy ,Centers For Disease ,Yale School Of Medicine ,Action Fund ,Biomedical Advanced Research ,National Institutes Of Health ,Development Authority ,Johns Hopkins University Center ,University Of Pittsburgh ,Wellcome ,George Washington University School Of Medicine ,Health Security ,Infectious Diseases Society Of America ,Los Angeles ,Pioneering Antimicrobial Subscriptions ,End Upsurging Resistance ,Colorado Democrat ,Indiana Republican ,Pennsylvania Democrat ,Infectious Diseases Society ,Public Citizen ,National Institutes ,Yale School ,George Washington University School ,Disease Control ,Antibiotics ,Igecycline ,Bacteria ,Antimicrobial Resistance ,Microbicides ,Hospitals ,Practice Management ,Geriatrics Elder Care ,Salary Compensation ,Social Determinants Of Health ,Boards ,Smle ,Cancer ,Alignant Neoplasia ,Arcinoma , ,Financing ,Grant ,Insurance ,Medicaid ,Medicare ,Nightmares ,Eye ,Rural Health ,Ural Medicine ,Washington ,Neuroendocrine Tumor ,Sleep Disorder ,Vaccin ,